How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
New VentureBeat survey data: 85% of enterprises run contested AI platforms with no single owner, and only 10% can ...
As AI transforms education, we must redefine intelligence beyond biological limits and embrace cognitive functions across ...
While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...
Recursive Self-Improvement Now Has a Co-Evolving Evaluator: Cambridge-NVIDIA Paper Raises the Stakes
Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...
Recursion Pharmaceuticals is trying to prove that AI’s next big winner can also come from biotech, and not just from the tech ...
Integrating humanities into AI development is vital because societal impact is shaped by those who understand meaning, not just builders.
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
Google DeepMind's new report maps four pathways from AGI to artificial superintelligence. Here's how scaling, paradigm shifts ...
Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...
Most security teams think of NTFS junctions and symbolic links as niche file system features. They let one directory point to another, like a shortcut that the OS treats as real. They exist for ...
Ben Taylor, CFO of Recursion, here with us. Thanks so much for joining us. Sure. Great. And first of all, thanks for having us here, Tommie. This is always a terrific conference and great to be here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results